
Samer Al Hadidi, M.D., M.S.
BCMA Saturation: Redundancy or Real Choice?
Samer Al Hadidi, M.D., M.S., is an Associate Professor of Internal Medicine at UT Southwestern Medical Center, specializing in hematology and oncology with a focus on plasma cell disorders—including multiple myeloma and light chain amyloidosis—and cellular therapies like CAR T-cell therapy and stem cell transplantation.
He earned his medical degree at the University of Jordan and completed fellowship training at Baylor College of Medicine, plus a master’s in clinical research from the University of Michigan. Dr. Al Hadidi is Clinical Director of UT Southwestern’s Amyloidosis Program, serves on the ABIM Hematology Specialty Board, and has published over 140 peer-reviewed articles.